Showing results (101-110 of 309) with videos related to

Sort By:
Pageof 31
Leukemia Research|October 23, 1998
Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell lineR Munker, S Zhao, S Jiang, et al.
Onkologie|August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]W Hiddemann, T Büchner, M Andreeff, et al.
Blood|February 15, 1991
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotypeE Berman, M Adams, R Duigou-Osterndorf, et al.
Blood|February 1, 1980
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNAM Andreeff, Z Darzynkiewicz, T K Sharpless, et al.
Oncogene|December 7, 1995
Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosisT Kobayashi, U Consoli, M Andreeff, et al.
Cytotherapy|November 6, 2008
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foeS Kidd, E Spaeth, A Klopp, et al.
British Journal of Haematology|August 1, 1985
DNA and RNA determination in 111 cases of childhood acute lymphoblastic leukaemia (ALL) by flow cytometry: correlation of FAB classification with DNA stemline and proliferationC Suarez, D R Miller, P G Steinherz, et al.
Blood|June 22, 2001
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaS Ibrahim, M Keating, K A Do, et al.
British Journal of Haematology|August 6, 2000
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donorsP Anderlini, M Donato, M J Lauppe, et al.
Transfusion|June 23, 1999
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experienceP Anderlini, M Donato, K W Chan, et al.
Pageof 31